Viatris Inc reported revenue of $3.76B for the period ended 2026-06-30, +4.9% year on year. Net income was $-0.12B, a -3.2% net margin on a 38.8% gross margin. The largest revenue line is Brands at 30% of the total. Free cash flow for the period was $0.32B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $3.76B | +4.9% |
| Gross profit | $1.46B | — |
| Operating income | $0.01B | — |
| Net income | $-0.12B | — |
| Gross margin | 38.8% | Net margin -3.2% |
| Revenue Q/Q | +6.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| Brands | $1.12B | 29.9% |
| Generics | $1.07B | 28.5% |
| Greater China | $0.71B | 19.0% |
| Emerging Markets | $0.54B | 14.5% |
| Japan Australia And New Zealand | $0.30B | 7.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $2.30B | 61.2% |
| R&D | $0.25B | 6.6% |
| SG&A | $1.13B | 30.2% |
| Tax & other | $0.13B | 3.3% |
| Item | Amount |
|---|---|
| Total assets | $35.04B |
| Total liabilities | $20.78B |
| Shareholders' equity | $14.26B |
| Equity / assets | 40.7% |
| Operating cash flow | $0.38B |
| Capital expenditure | $0.06B |
| Free cash flow | $0.32B |
| Cash conversion (OCF / net income) | -321% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
VICI ・ V ・ VST ・ VMC ・ WRB ・ GWW ・ WAB ・ WMT ・ DIS ・ WBD ・ WM ・ WAT
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies